(Q36386468)

13 August 2017

p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans (English)

1 reference

13 August 2017

7

Aurelia Noske

0 references

Kristian Ikenberg

2

object named as

Kristian Ikenberg

0 references

Holger Moch

12

object named as

Holger Moch

1 reference

13 August 2017

Peter J Wild

1

1 reference

13 August 2017

Thomas J Fuchs

3

1 reference

13 August 2017

Markus Rechsteiner

4

1 reference

13 August 2017

Strahil Georgiev

5

1 reference

13 August 2017

Niklaus Fankhauser

6

1 reference

13 August 2017

Matthias Roessle

8

1 reference

13 August 2017

Rosmarie Caduff

9

1 reference

13 August 2017

Athanassios Dellas

10

1 reference

13 August 2017

Daniel Fink

11

1 reference

13 August 2017

Wilhelm Krek

13

1 reference

13 August 2017

Ian J Frew

14

1 reference

13 August 2017

8 June 2012

1 reference

13 August 2017

EMBO Molecular Medicine

1 reference

13 August 2017

4

1 reference

13 August 2017

808-824

1 reference

13 August 2017

8

1 reference

High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

30 September 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

A proposed model for endometrial serous carcinogenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

30 September 2017

p53-based cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Revised FIGO staging for carcinoma of the endometrium

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Insights into endometrial serous carcinogenesis and progression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Endometrial Glandular Dysplasia with Frequent p53 Gene Mutation: A Genetic Evidence Supporting Its Precancer Nature for Endometrial Serous Carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Endometrial glandular dysplasia and endometrial intraepithelial neoplasia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Endometrial carcinoma: pathology and genetics.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Precursors of endometrial clear cell carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Co-expression of p53 by epithelial and stromal elements in carcinosarcoma of the female genital tract: an immunohistochemical study of 19 cases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Tissue microarrays for high-throughput molecular profiling of tumor specimens

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumours

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

Molecular characterization of uterine clear cell carcinoma

28 June 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Immunophenotyping of serous carcinoma of the female genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

Pax8: a marker for carcinoma of Müllerian origin in serous effusions.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494078

21 September 2018

Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEMMM.201101063

HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients

21 January 2018

1 reference

12 December 2020

Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features

1 reference

12 December 2020

p53 protein overexpression and gene mutation in mixed Müllerian tumors of the uterus

1 reference

12 December 2020

Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components

1 reference

12 December 2020

Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors

1 reference

12 December 2020

Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies

1 reference

12 December 2020

PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia

1 reference

12 December 2020

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

1 reference

12 December 2020

Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation

1 reference

12 December 2020

Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma

1 reference

12 December 2020

Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1002/EMMM.201101063

1 reference

13 August 2017

1 reference

13 August 2017

1 reference